Work

Supplementary Data from Phase I Immunotherapy Trial with Two Chimeric HER-2 B-Cell Peptide Vaccines Emulsified in Montanide ISA 720VG and Nor-MDP Adjuvant in Patients with Advanced Solid Tumors

Year: 2023
Type: supplementary-materials
Abstract: This file contains supplemental materials, tables, and figures.
Language: English
Subfield: Immunology
Open Access status: gold
OpenAlex ID: W4361936472
Cites:
Cited by:
Related to: 10